| Autor: |
Jaka Pradipta, Hubertus Hosti Hayuanta, Mururul Aisyi, Ahmad Rusdan Handoyo Utomo, Chainurridha Chainurridha, Fifi Dwijayanti |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Asian Pacific Journal of Cancer Care. 6:41-49 |
| ISSN: |
2588-3682 |
| DOI: |
10.31557/apjcc.2021.6.s1.41-49 |
| Popis: |
Introduction: Cancer patients have an increased risk of morbidity and mortality due COVID-19 partly due to their immunocompromised status. We aimed to investigate the associations of clinicopathological factors and survival outcomes in cancer patients with COVID-19. Methods: This was a retrospective cohort study comprised of cancer patients treated in Dharmais National Cancer Center, Indonesia. Main inclusion criteria were pathologically confirmed malignancy with positive results of RTPCR COVID-19 tests. Results: A total of 16,511 visitors had visited and registered for RTPCR test in Dharmais National Cancer Center from May 2020 to January 2021. Logistic regression showed that male gender (p-value = 0.019; OR = 1.732), haematological type of malignancy (p-value |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
